194 related articles for article (PubMed ID: 24778618)
1. Age-related changes of protein SUMOylation balance in the AβPP Tg2576 mouse model of Alzheimer's disease.
Nisticò R; Ferraina C; Marconi V; Blandini F; Negri L; Egebjerg J; Feligioni M
Front Pharmacol; 2014; 5():63. PubMed ID: 24778618
[TBL] [Abstract][Full Text] [Related]
2. Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model.
McMillan LE; Brown JT; Henley JM; Cimarosti H
Neurosci Lett; 2011 Sep; 502(3):201-8. PubMed ID: 21843595
[TBL] [Abstract][Full Text] [Related]
3. Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease.
Lee L; Dale E; Staniszewski A; Zhang H; Saeed F; Sakurai M; Fa' M; Orozco I; Michelassi F; Akpan N; Lehrer H; Arancio O
Sci Rep; 2014 Dec; 4():7190. PubMed ID: 25448527
[TBL] [Abstract][Full Text] [Related]
4. [Potential involvement of abnormal increased SUMO-1 in modulation of the formation of Alzheimer's disease senile plaques and neuritic dystrophy in APP/PS1 transgenic mice].
Zhao XY; Wang DD; Shan Y; Zhu CQ
Sheng Li Xue Bao; 2013 Jun; 65(3):253-62. PubMed ID: 23788181
[TBL] [Abstract][Full Text] [Related]
5. Aging-related SUMOylation pattern in the cortex and blood plasma of wild type mice.
Ficulle E; Sufian MDS; Tinelli C; Corbo M; Feligioni M
Neurosci Lett; 2018 Mar; 668():48-54. PubMed ID: 29325714
[TBL] [Abstract][Full Text] [Related]
6. Targeting SUMO-1ylation Contrasts Synaptic Dysfunction in a Mouse Model of Alzheimer's Disease.
Marcelli S; Ficulle E; Iannuzzi F; Kövari E; Nisticò R; Feligioni M
Mol Neurobiol; 2017 Oct; 54(8):6609-6623. PubMed ID: 27738871
[TBL] [Abstract][Full Text] [Related]
7. SUMO and Alzheimer's disease.
Lee L; Sakurai M; Matsuzaki S; Arancio O; Fraser P
Neuromolecular Med; 2013 Dec; 15(4):720-36. PubMed ID: 23979993
[TBL] [Abstract][Full Text] [Related]
8. Modulation of inducible nitric oxide synthase expression by sumoylation.
Akar CA; Feinstein DL
J Neuroinflammation; 2009 Mar; 6():12. PubMed ID: 19323834
[TBL] [Abstract][Full Text] [Related]
9. The pivotal role of SUMO-1-JNK-Tau axis in an in vitro model of oxidative stress counteracted by the protective effect of curcumin.
Buccarello L; Dragotto J; Iorio F; Hassanzadeh K; Corbo M; Feligioni M
Biochem Pharmacol; 2020 Aug; 178():114066. PubMed ID: 32502496
[TBL] [Abstract][Full Text] [Related]
10. Battling Alzheimer's Disease: Targeting SUMOylation-Mediated Pathways.
Martins WC; Tasca CI; Cimarosti H
Neurochem Res; 2016 Mar; 41(3):568-78. PubMed ID: 26227998
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of Adenovirus E4-ORF3-Mediated SUMO Modifications.
Sohn SY; Hearing P
mBio; 2019 Feb; 10(1):. PubMed ID: 30808699
[TBL] [Abstract][Full Text] [Related]
12. SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression.
Bawa-Khalfe T; Yeh ET
Genes Cancer; 2010 Jul; 1(7):748-752. PubMed ID: 21152235
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus regulates sumoylation of Mre11-Rad50-Nbs1 components through a paralog-specific mechanism.
Sohn SY; Hearing P
J Virol; 2012 Sep; 86(18):9656-65. PubMed ID: 22740413
[TBL] [Abstract][Full Text] [Related]
14. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
15. Is Transthyretin a Regulator of Ubc9 SUMOylation?
Wieczorek E; Kędracka-Krok S; Sołtys K; Jankowska U; Hołubowicz R; Seliga J; Ożyhar A
PLoS One; 2016; 11(8):e0160536. PubMed ID: 27501389
[TBL] [Abstract][Full Text] [Related]
16. Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction.
Kim EY; Chen L; Ma Y; Yu W; Chang J; Moskowitz IP; Wang J
J Mol Cell Cardiol; 2012 Mar; 52(3):638-49. PubMed ID: 22155005
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation: Novel Neuroprotective Approach for Alzheimer's Disease?
Hoppe JB; Salbego CG; Cimarosti H
Aging Dis; 2015 Sep; 6(5):322-30. PubMed ID: 26425387
[TBL] [Abstract][Full Text] [Related]
18. SUMO-1 immunoreactivity co-localizes with phospho-Tau in APP transgenic mice but not in mutant Tau transgenic mice.
Takahashi K; Ishida M; Komano H; Takahashi H
Neurosci Lett; 2008 Aug; 441(1):90-3. PubMed ID: 18586401
[TBL] [Abstract][Full Text] [Related]
19. Arachidonic or Docosahexaenoic Acid Diet Prevents Memory Impairment in Tg2576 Mice.
Hosono T; Mouri A; Nishitsuji K; Jung CG; Kontani M; Tokuda H; Kawashima H; Shibata H; Suzuki T; Nabehsima T; Michikawa M
J Alzheimers Dis; 2015; 48(1):149-62. PubMed ID: 26401936
[TBL] [Abstract][Full Text] [Related]
20. SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.
Chen AJ; Gao L; Wang XW; Zhao XF; Wang JX
J Virol; 2013 Jan; 87(1):636-47. PubMed ID: 23097446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
